NASDAQ
Harmony Biosciences Holdings, Inc. (HRMY) has a current ratio of 3.60x as of Tuesday, May 26, 2026. This represents a 12.40% decrease compared to its 12-month average of 4.11x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.